News

Paracervical block for laparoscopic supracervical hysterectomy yields mixed results


 

AT SGS 2014

Results showed that the paracervical block and control groups were statistically indistinguishable with respect to the overall admission rate (41% vs. 28%) and the unplanned admission rate (34% vs. 27%). In the subset with an unplanned admission, 21 women were admitted for pain management: 10 in the paracervical-block group and 11 in the control group.

Use of fentanyl and use of oxycodone while in the postanesthesia care unit did not differ significantly between groups. However, in the first 14 days after surgery, the paracervical block group consumed fewer tablets of narcotics per day (0.58 vs. 0.71) and more tablets of over-the-counter analgesics per day (1.02 vs. 0.77). Mean pain scores during the first 2 postoperative days were essentially the same.

"Maybe the patients who didn’t have the block were using narcotics more to achieve a lower pain score. That’s one way to think about it," Dr. Barr proposed.

The two groups had similar rates of perioperative outcomes such as operative time and complications. Estimated median blood loss was generally low, but significantly lower in the paracervical block group.

"Out of all 132 patients, we only had 7 patients who had a blood loss greater than or equal to 500 mL, and the largest blood loss was 900 mL. Also, there were no transfusions," she pointed out.

Three patients – two in the paracervical block group and one in the control group – developed a cervical infection after surgery. All were successfully treated with oral antibiotics.

"The hysterectomies were all supracervical so the results may not apply to total hysterectomies, and we did not control for additional procedures performed at the same time," Dr. Barr noted.

Dr. Barr disclosed no relevant conflicts of interest.

Pages

Recommended Reading

Putting morcellation into perspective – ‘Just the facts, Ma’am, nothing but the facts’
MDedge ObGyn
U.S. tracking of HPV in cervical precancers confirms half due to 16/18
MDedge ObGyn
Whole-genome sequencing not ready for prime time
MDedge ObGyn
FDA Advisory Committee recommends HPV test as primary screening tool for cervical cancer
MDedge ObGyn
Obesity: American Association of Clinical Endocrinology (AACE)
MDedge ObGyn
Biomarkers identified that predict residual disease in ovarian cancer
MDedge ObGyn
Vaginal cuff brachytherapy plus chemotherapy no better than pelvic radiation in early endometrial cancer
MDedge ObGyn
Resident involvement does not compromise safety of laparoscopic hysterectomy
MDedge ObGyn
Foley guide likely unnecessary during midurethral sling surgery
MDedge ObGyn
Draft recommendations back aspirin for preeclampsia prevention
MDedge ObGyn